info icon

This is a non-core endpoint: only basic statistics are computed.

Melanoma in situ of eyelid, including canthus

CD2_INSITU_MELANOMA_EYELID_EXALLC

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

None

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 D03.1&
  • Cause of death: ICD-10 D03.1&

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D03
Name in latin
Melanoma in situ palpebrae

Case counts by codes

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 21 11 10
Unadjusted period prevalence (%) 0.00 0.00 0.00
Median age at first event (years) 64.56 65.07 64.00

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
13
47
5.58
3.55
3.9
1.5
—
—
—
0
0
5
13
4.68
1.83
2.0
1.1
—
—
—
0
0
11
60
2.75
1.35
3.7
4.2
—
—
—
0
0
21
184
+∞
0.85
15.8
12.2
—
—
—
0
0
16
126
2.13
0.78
5.6
4.2
—
—
—
0
0
8
49
2.02
0.74
2.5
1.8
54.6
65.5
u/l
—
8
42
6
35
1.99
0.65
7.7
4.4
—
—
—
0
0
0
22
0.00
0.63
0.0
1.0
—
125.0
—
0
5
7
49
1.64
0.53
2.6
3.4
—
—
—
0
0
6
45
1.46
0.38
1.3
1.4
—
—
—
0
0
7
50
1.60
0.37
3.4
2.7
—
—
—
0
0
7
51
1.56
0.37
2.1
3.7
—
—
—
0
0
5
39
1.37
0.25
2.4
4.0
—
—
—
0
0
6
47
1.39
0.23
3.0
2.3
—
—
—
0
0
0
11
0.00
0.22
0.0
1.5
—
—
—
0
0
0
10
0.00
0.22
0.0
9.2
—
0.7
—
0
10
0
10
0.00
0.22
0.0
9.2
—
95.2
—
0
10
8
68
1.28
0.20
2.4
3.9
—
—
—
0
0
5
42
1.25
0.11
2.2
4.4
—
1.0
—
0
7
5
43
1.21
0.11
4.6
3.8
—
—
—
0
0
14
145
0.90
0.09
19.5
18.3
332.2
331.8
g/l
0.05
14
145
12
130
0.82
0.09
4.3
4.5
—
—
—
0
0
12
110
1.21
0.09
2.9
4.3
6.3
6.9
mmol/l
0.73
12
103
0
5
0.00
0.00
0.0
4.4
—
55.8
—
0
5
0
5
0.00
0.00
0.0
10.6
—
1.0
—
0
5
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
4.8
—
0
5
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.7
—
20.8
—
0
8
0
6
0.00
0.00
0.0
1.8
—
183.1
—
0
6
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
5
57
0.84
0.00
1.8
1.5
1.1
1.2
mmol/l
—
5
46
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
5
51
0.97
0.00
3.8
3.1
0.0
0.6
e6/l
—
5
39
7
71
0.98
0.00
2.7
3.2
77.6
131.4
ug/l
—
7
63
6
60
1.00
0.00
5.5
5.9
—
—
—
0
0
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: CD2_INSITU_MELANOMA_EYELID_EXALLC – Melanoma in situ of eyelid, including canthus

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).